DAVID POORVIN, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

ENANTA PHARMACEUTICALS INC

Filing Date Source Excerpt
2014-01-10 David Poorvin, Ph.D.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22